Home Print this page Email this page Small font size Default font size Increase font size
Users Online: 3820
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others


Effect of neoadjuvant chemotherapy (NAC) on programmed cell death ligand (PD-L1) in patients of carcinoma breast: A prospective study in Indian tertiary care setting

Srivastava Vipul, Akshay B R, Kumari Sweety, Meena Ram Niwas, Khanna Rahul

Year : 2020| Volume: 9| Issue : 8 | Page no: 4086-4091

   This article has been cited by
1 PD-L1 Expression after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancers Is Associated with Aggressive Residual Disease, Suggesting a Potential for Immunotherapy
Beatriz Grandal,Manon Mangiardi-Veltin,Enora Laas,Marick Lať,Didier Meseure,Guillaume Bataillon,Elsy El-Alam,Lauren Darrigues,Elise Dumas,Eric Daoud,Anne Vincent-Salomon,Laure-Sophie Talagrand,Jean-Yves Pierga,Fabien Reyal,Anne-Sophie Hamy
Cancers. 2021; 13(4): 746
[Pubmed]  [Google Scholar] [DOI]


Read this article